CFW |
CFW-YN703600U |
10mg-1g |
咨询 |
957054-30-7 |
GDC-0941 |
分析标准品 |
咨询
|
请联系客服购买!
|
罗恩 |
R022978-10mg |
10mg |
5~7个工作日 |
957054-30-7 |
4-羟基-2,6-二甲基苯甲腈 pictrelisi |
98% |
523.00
523.00
|
|
罗恩 |
R022978-250mg |
250mg |
5~7个工作日 |
957054-30-7 |
4-羟基-2,6-二甲基苯甲腈 pictrelisi |
98% |
5,173.00
5,173.00
|
|
罗恩 |
R022978-50mg |
50mg |
5~7个工作日 |
957054-30-7 |
4-羟基-2,6-二甲基苯甲腈 pictrelisi |
98% |
1,977.00
1,977.00
|
|
TRC |
G601510-10mg |
10mg |
预期库存 |
957054-30-7 |
GDC-0941 |
|
1,778.00
1,778.00
|
|
TRC |
G601510-50mg |
50mg |
预期库存 |
957054-30-7 |
GDC-0941 |
|
4,270.00
4,270.00
|
|
TRC |
G601510-100mg |
100mg |
预期库存 |
957054-30-7 |
GDC-0941 |
|
7,322.00
7,322.00
|
|
阿法埃莎 |
C46786-100MG |
100MG |
现货 |
957054-30-7 |
Pictilisib, 95% Pictilisib, 95% |
|
3,936.00
3,936.00
|
|
毕得 |
BD167199-5mg |
5mg |
现货 |
957054-30-7 |
2-(1H-吲唑-4-基)-6-(4-甲磺酰哌嗪-1-基... 4-(2-(1H-Indazol-4-yl)-6-((4... |
98+% |
256.00
256.00
|
|
毕得 |
BD167199-10mg |
10mg |
现货 |
957054-30-7 |
2-(1H-吲唑-4-基)-6-(4-甲磺酰哌嗪-1-基... 4-(2-(1H-Indazol-4-yl)-6-((4... |
98+% |
435.00
435.00
|
|
毕得 |
BD167199-50mg |
50mg |
现货 |
957054-30-7 |
2-(1H-吲唑-4-基)-6-(4-甲磺酰哌嗪-1-基... 4-(2-(1H-Indazol-4-yl)-6-((4... |
98+% |
1,567.00
1,567.00
|
|
毕得 |
BD167199-1mg |
1mg |
现货 |
957054-30-7 |
2-(1H-吲唑-4-基)-6-(4-甲磺酰哌嗪-1-基... 4-(2-(1H-Indazol-4-yl)-6-((4... |
98+% |
86.00
86.00
|
|
Acros |
C46786-100MG |
100MG |
现货 |
957054-30-7 |
Pictilisib, 95% Pictilisib, 95% |
|
4,630.00
4,630.00
|
|
阿拉丁 |
G126357-10mg |
10mg |
现货 |
957054-30-7 |
GDC-0941,有效的PI3K抑制剂 GDC-0941 |
≥98% |
435.90
435.90
|
|
阿拉丁 |
G126357-50mg |
50mg |
现货 |
957054-30-7 |
GDC-0941,有效的PI3K抑制剂 GDC-0941 |
≥98% |
1,647.90
1,647.90
|
|
阿拉丁 |
G126357-250mg |
250mg |
现货 |
957054-30-7 |
GDC-0941,有效的PI3K抑制剂 GDC-0941 |
≥98% |
4,310.90
4,310.90
|
|
阿拉丁 |
P408768-1ml |
1ml |
期货,请咨询 |
957054-30-7 |
Pictilisib (GDC-0941) Pictilisib (GDC-0941) |
10mM in DMSO |
715.90
715.90
|
|